Spirogen Ltd.

ADC Therapeutics SARL is aiming to file a biologics license application for its antibody-drug conjugate loncastuximab tesirine (ADCT-402, aka Lonca) in the second half of 2020 following presentation

Having a realistic view of the amount of funding required to take a potential medicine through clinical trials could be thought a prime requirement of a biotech company, one being exhibited by Lausann

"The Pink Sheet" regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy transactions that occurred between April 2-1

"The Pink Sheet" regularly covers noteworthy deal-making in the biopharmaceutical industry. Here is a roundup of key transactions occurring between Sept. 19 and Oct. 2. Genzyme/Alnylam Alnylam Phar